Current Consultations

Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.

The following lists both consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia updates this regularly but we may not participate in every one listed.

If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia via email greg.mullins@researchaustralia.org or phone (03) 9662 9420.

Please click the heading in the left hand column to access consultation information from the relevant website.

 

 

Consultation

Details

Inclusion of Class I medical devices in the Australian Register of Therapeutic Goods (ARTG)

 

Due 1 January 2021

Class I medical devices which are non-sterile and non-measuring, are considered low risk devices. Until now, medical devices have been incorrectly included as Class I or applications have been found to be incomplete or inaccurate.

The TGA has undertaken amendments to the Class I medical devices inclusion process, to address these issues.

Feedback on the amendments is sought via an online survey.

Pre- Budget Submissions

 

Due 29 January 2021

The Australian Government has made the annual call for Pre-Budget submissions from individuals, businesses and community groups on their views regarding priorities for the 2021-22 Budget.

Research Australia is preparing a submission. To contribute to our submission, please contact Greg Mullins, Head of Policy, at greg.mullins@researchaustralia.org

WA Genomics Health Strategy

 

Due 31 January 20201

The WA Government is consulting the draft WA Health Genomics Strategy 2021 to inform the development of the first implementation plan. This consultation consists of two parts:

·       Part 1 will seek feedback on the draft Strategy; in particular the vision, underlying principles, enablers of success, key priority areas, goals, and initiatives.

·       Part 2 will seek opinions on the three horizons proposed for the Strategy’s implementation and priority actions for focussing efforts and resources in the first two years.

A discussion paper outlining the key findings from the initial stakeholder engagement is available here.

Productivity Commission Report on Mental Health

Due 10 February 2021

The Department of Health is seeking comments on the Productivity Commission’s Report on Mental Health. The report provides 21 recommendations with 103 associated actions.

The report makes recommendations on the better use of data and for more research to be undertaken; the latter includes establishing a mental health clinical trials network.

Research Australia is preparing a submission. To contribute to our submission, please contact Greg Mullins, Head of Policy, at greg.mullins@researchaustralia.org

MRFF Mission Consultations

 

Due 23 April 2021

The Department of Health is undertaking consultations on the Roadmap and Implementation Plan for each of the following MRFF Missions:

·       Cardiovascular Health

·       Traumatic Brain Injury

·       Genomics

·       Stem Cell Therapies

·       Dementia, Ageing and Aged Care

·       Indigenous Health

Each Mission’s Roadmap is a high level strategic document that includes the aim, vision, goal and priorities for investment for the Mission. To support the Roadmap, the Implementation Plan outlines the priorities for investment (short, medium and long term), evaluation approaches and measures, supporting activities, and collaborative opportunities.

National Gene Technology Scheme- Regulatory Framework

 

Due 17 March 2021

The National Gene Technology Scheme has been reviewed and the Department of Health is now consulting on different options for the Regulatory Framework to implement the recommendations.

A Regulatory Impact Statement and Explanatory Paper are available to guide the consultation. It is not necessary to respond  to all questions, just those that are relevant to you.

Submissions may be lodged via email at Gene.Technology.Implementation@health.gov.au, although electronic lodgement via the consultation hub is preferred.

Select Committee on COVID-19

 

 

On 8 April 2020, the Senate resolved to establish a Select Committee on COVID-19 to inquire into the Australian Government’s response to the COVID-19 pandemic.

The terms of reference are very broad:

    1. the Australian Government’s response to the COVID-19 pandemic; and
    2. any related matters.

Research Australia has made a submission to the Inquiry, which is available here.

The Committee is to present its final report on or before 30 June 2022.